Peak Pharmaceuticals, Inc.
PKPH
Other OTC1.55
USD
- -
- -
Total Valuation
Peak Pharmaceuticals, Inc. carries a market capitalization of 607,316.00, placing it among publicly traded companies globally.
| Market Cap | 607,316.00 |
| Enterprise Value | N/A |
Stock Price Statistics
Peak Pharmaceuticals, Inc.'s stock has declined approximately -84.65347% over the past 52 weeks. The 50-day moving average sits at 3.20, while the 200-day moving average is 11.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -84.65347% |
| 50-Day Moving Average | 3.20 |
| 200-Day Moving Average | 11.27 |
| Average Volume (20 Days) | N/A |
Stock Splits
Peak Pharmaceuticals, Inc.'s most recent stock split took place on February 15, 2023 with a 200:1 split ratio.
| Last Split Date | 2/15/2023 |
| Split Ratio | 200:1 |